What are the guidelines for a DEXA (Dual-Energy X-ray Absorptiometry) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for DEXA Scan

DEXA (Dual-Energy X-ray Absorptiometry) scans should be performed in women aged 65 years and older, men aged 70 years and older, and earlier in individuals with specific risk factors for osteoporosis to reduce morbidity and mortality from fragility fractures. 1, 2

Recommended Screening Population

Age-Based Recommendations:

  • Women:
    • Age 65 years and older: Universal screening
    • Age 50-64 years: Selective screening based on risk factors
  • Men:
    • Age 70 years and older: Universal screening
    • Age 50-69 years: Selective screening based on risk factors

High-Risk Individuals (Any Age) Who Should Be Screened:

  • History of fragility fracture
  • Long-term glucocorticoid therapy (current or recent)
  • Height loss ≥ 1.5 inches (historical) or ≥ 0.8 inches (prospective)
  • Medical conditions associated with bone loss:
    • Hyperparathyroidism
    • Rheumatoid arthritis
    • Malabsorption syndromes
    • Chronic inflammatory conditions
  • Androgen deprivation therapy for prostate cancer
  • Premature menopause or hypogonadism
  • Spinal cord injury

Anatomical Sites for Measurement

Primary Sites:

  • Lumbar spine (L1-L4)
  • Proximal femur (total hip and femoral neck)

Secondary Sites (When Primary Sites Cannot Be Assessed):

  • Distal forearm (one-third radius)
  • For spinal cord injury patients: total hip, proximal tibia, and distal femur

Diagnostic Classification (WHO Criteria)

T-score Diagnosis
> -1.0 Normal
-1.0 to -2.4 Osteopenia (Low bone mass)
≤ -2.5 Osteoporosis

Follow-up Recommendations

  • Normal BMD: Every 2-3 years
  • Osteopenia: Every 2 years
  • Osteoporosis on treatment: 1-2 years after initiating therapy, then every 2 years
  • High-risk for rapid bone loss: Annual scans (e.g., glucocorticoid therapy)
  • After fracture or development of new risk factors: Immediate reassessment

Special Populations

Transgender Individuals:

  • Z-scores should be calculated using reference data conforming with the individual's gender identity
  • For gender non-conforming individuals, use reference data for sex recorded at birth

Spinal Cord Injury:

  • DXA scan as soon as medically stable
  • Include evaluation of total hip, distal femur, and proximal tibia
  • Follow-up every 1-2 years

Common Pitfalls to Avoid

  1. Positioning errors: Ensure proper patient positioning

  2. Artifacts: Identify and account for:

    • Degenerative changes in spine (exclude affected vertebrae)
    • Vertebral fractures (exclude affected vertebrae)
    • Surgical hardware or prostheses (scan contralateral side)
    • Aortic calcification
  3. Interpretation errors:

    • Using T-scores instead of absolute BMD values (g/cm²) for follow-up comparisons
    • Not using the same DXA machine for serial measurements
    • Not accounting for height/size differences in very tall or short individuals
  4. Reporting errors:

    • Incomplete documentation of patient demographics and risk factors
    • Failure to note technical limitations or artifacts

Components of a Standard DXA Report

  • Patient demographics (name, age, sex, height, weight)
  • Menopausal status (if applicable)
  • Indication for testing
  • Technical quality and limitations
  • BMD measurements in g/cm² and T-scores for each site
  • Fracture risk assessment (FRAX if appropriate)
  • Diagnosis based on WHO criteria
  • Recommendations for follow-up

By following these guidelines, clinicians can appropriately utilize DEXA scanning to identify patients at risk for osteoporotic fractures and implement timely interventions to reduce morbidity and mortality associated with fragility fractures.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Osteoporosis Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.